Short answer
Vanda Pharmaceuticals Inc. (VNDA) filed an 8-K current report with the SEC on April 2, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Timothy Williams resigning as Senior Vice President, General Counsel and Secretary effective April 10, 2026.
Vanda Pharmaceuticals Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Timothy Williams resigning as Senior Vice President, General Counsel and Secretary effective April 10, 2026
- Departure to pursue other endeavors, indicating an executive transition rather than disclosed performance-related removal
- Legal leadership vacancy may affect regulatory, litigation and corporate-governance oversight during the succession period
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Vanda Pharmaceuticals Inc. 8-K filings
Get the next VNDA 8-K as it lands
Follow VNDA for push alerts, or ask the research agent what this filing means.